Chemical and Pharmaceutical Bulletin p. 1685 - 1693 (1999)
Update date:2022-08-05
Topics:
Ono, Shin'ichiro
Inoue, Yoshihisa
Yoshida, Tomohiro
Ashimori, Atsuyuki
Kosaka, Keigo
Imada, Teruaki
Fukaya, Chikara
Nakamura, Norifumi
The synthesis and design using molecular modeling techniques for non- peptide, low molecular weight novel fibrinogen receptor (glycoprotein IIb/IIIa: Gp IIb/IIIa) antagonists, is reported. We used a highly potent serine protease inhibitor, Nafamostat, having an amidinonaphthyl unit as the starting compound. The compounds 4-(6-amidino-2- naphthylaminocarbonyl)phenoxyacetic acid (5a) and 4-(6-amidino-2- naphthalenecarboxamido)phenoxyacetic acid (5b) inhibited adenosin-5'- diphospate (ADP)-induced aggregation of human platelet-rich plasma (PRP) with IC50 values of 0,05 and 0.07 μM, respectively, and had lost their ability to inhibit a variety of serine proteases, including thrombin, factor Xa, plasmin and trypsin.
View MoreShanghai He Yang International Trading Co., Ltd.
Contact:+86-21-52043598
Address:Room 816, Blag.5, No.58 Huachi Road
Laohekou huacheng Trade Co., Ltd.
Contact:+86-710-8360685
Address:No. 85, Beijing Road, Laohekou City, Hubei Province, China
Nanjing Fayekong Chemcial Co.,Ltd
Contact:86-25-58813444
Address:Rm 1503, Unit 1, Building 5, Zijinnanyuan, Nanjing, Jiangsu, China
Zhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Jiangyin Tenghua Import&Export Co.,Ltd.
Contact:+86-510-86263875
Address:Room 402-B,9 Yanling Road, Jiangyin,Jiangsu, China
Doi:10.1246/bcsj.66.2931
(1993)Doi:10.1021/acs.orglett.5b01733
(2015)Doi:10.1021/ja00152a008
(1995)Doi:10.1002/asia.201402595
(2015)Doi:10.1021/ja00143a029
(1995)Doi:10.1055/s-1995-4026
(1995)